Biotechnology News

July 27, 2012

AUSTIN, Texas--(BUSINESS WIRE)--ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, plans to announce its second quarter 2012 results on Wednesday, August 1, 2012. ArthroCare plans to...

July 27, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--Bracco Diagnostics Inc., the US-based company of the Bracco Group – one of the world’s leading companies in the diagnostic imaging business – today announced that the U.S. Food and Drug Administration (FDA) has...

July 27, 2012

AIX-EN-PROVENCE, France--(BUSINESS WIRE)--SuperSonic Imagine announces the production of its 500th Aixplorer® ultrasound system in the world

July 27, 2012

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Neurotez, Inc. today announced the grant of U.S. Patent number 8,227,408 by the United States Patent and Trademark Office covering the company’s lead product candidate, Leptin. The patent protects use of the...

July 27, 2012

ANN ARBOR, Mich. & WASHINGTON--(BUSINESS WIRE)--NSF International, an independent global public health and safety organization, has acquired Becker & Associates Consulting, Inc., a leading clinical, regulatory and scientific consulting...

July 27, 2012

CHARLOTTE, N.C.--(BUSINESS WIRE)--Hospitals, healthcare providers to benefit from new Premier agreements for infant care capital equipment

July 27, 2012

LONDON--(BUSINESS WIRE)--New report "Pharmaceutical Leaders 2012 - Key Trends, Emerging Strategies and Financial Analysis of the Top Performers" provided by GlobalData has been recently published by Market Publishers Ltd.

July 27, 2012

NEW YORK--(BUSINESS WIRE)--Forest Laboratories, Inc. (NYSE: FRX) (“Forest”) announced that it has filed a presentation with the Securities and Exchange Commission (“SEC”) in connection with its Annual Meeting of Shareholders to be held on August...

July 27, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and neurotrauma, announced today that the trading symbol for its stock,...

July 27, 2012

GENEVA--(BUSINESS WIRE)--Vertex announced today that the European Commission has approved KALYDECO (ivacaftor) for people with CF ages 6 and older who have at least one copy of the G551D mutation in the CFTR gene.

July 27, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the BREVACTA study of ACTEMRA (tocilizumab) given as a subcutaneous (SC) injection to patients with rheumatoid...

July 26, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion announced that it has met the U.S. FDA requirements for pediatric exclusivity for LUNESTA. Sunovion has now gained an additional six months of U.S. market exclusivity.

July 26, 2012

NEW YORK--(BUSINESS WIRE)--BRISTOL-MYERS SQUIBB PRICES $2.0 BILLION OF SENIOR NOTES

July 26, 2012

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Foundation Marks World Hepatitis Day 2012 with New Grants; Focused on Hepatitis B and Hepatitis C Patient Empowerment in China and India

July 26, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--LCG Systems Awarded CIO-SP3 IDIQ Contract by National Institutes of Health

July 26, 2012

PORT WASHINGTON, N.Y.--(BUSINESS WIRE)--Pall's GeneDisc® test provides a fast screening method to identify common bacteria that are known to cause beer spoilage. Results are available from a given sample within one hour.

July 26, 2012

BETHESDA, Md. & DEERFIELD, Ill.--(BUSINESS WIRE)--Sucampo and Takeda today announced the filing of a supplemental new drug application with the US FDA seeking approval for a new indication for AMITIZA for the treatment of opioid-induced...

July 26, 2012

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the quarter ended June 30, 2012. Total revenues for the second quarter of 2012 increased 13 percent to $2.41 billion, from $2...

July 26, 2012

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Codexis, Inc. (NASDAQ:CDXS), a developer of cost-advantaged processes for the production of biofuels, bio-based chemicals, and pharmaceuticals, today announced it will host a conference call and webcast on...

July 26, 2012

AKRON, Ohio--(BUSINESS WIRE)--Healthy Life Screening is partnering with Akron General Medical Center to provide preventive cardiovascular and biometric screening services.

July 26, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced that the Company will...

July 26, 2012

SILVER SPRING, Md.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food & Drug Administration (FDA) Dermatologic & Ophthalmic Drugs Advisory Committee (DODAC) voted...

July 26, 2012

WASHINGTON--(BUSINESS WIRE)--Today, the House Subcommittee on Capital Markets held a hearing entitled “The 10th Anniversary of the Sarbanes-Oxley Act.” On behalf of the Biotechnology Industry Organization (BIO), Jeff Hatfield, President and CEO...

July 26, 2012

PARIS--(BUSINESS WIRE)--nouveau brevet

July 26, 2012

MINNEAPOLIS--(BUSINESS WIRE)--LifeScience Alley 2012 Conference registration opens. Health care, medical device, pharmaceutical and biotechnology leaders to speak and gather in Minneapolis on December 5, 2012.

July 26, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--A new study published by Cutting Edge Information details the benefits of incorporating brand teams in the managed markets decision making process.

July 26, 2012

STAMFORD, Conn.--(BUSINESS WIRE)--ArisGlobal, a top provider of software solutions to the life science industry, announced today that Mitsubishi Tanabe Pharma Corporation has gone live with a new generation of ArisGlobal’s comprehensive ARISg™...

July 26, 2012

CONCORD, Ohio--(BUSINESS WIRE)--Ricerce Biosciences today announced the introduction of two new state-of-the-art cellular assay services: Early Safety Screening Cytotoxicity and ImmunoSIGNAL™ Cytokine Storm Cellular Assay.

July 26, 2012

LAS VEGAS--(BUSINESS WIRE)--Research & Diagnostic Antibodies (R&D Antibodies) announced today that it has received a Notice of Allowance from the Japan Patent Office for its monoclonal antibody-based immunoassays and apparatuses for...

July 26, 2012

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq:SGEN) announced today that it will report its second quarter and year-to-date 2012 financial results on Wednesday, August 8, 2012, after the close of financial markets. Following the...

July 26, 2012

MT. OLIVE, N.J.--(BUSINESS WIRE)--The Sixth Annual Pinsonault Managed Markets Summit is pleased to announce a celebrated lineup of keynote speakers for the fall 2012 conference taking place September 19-21, 2012 in Las Vegas. The three-day...

July 26, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of neuropathic pain, less than half of surveyed primary care...

July 26, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX) and its subsidiary LifeMap Sciences, Inc. (“LifeMap”) today announced that LifeMap entered into a Share Exchange and Contribution Agreement with Alfred D. Kingsley and a company that...

July 26, 2012

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals, Inc. today announced that Platinum-Montaur Life Sciences, LLC (Montaur) will provide Navidea a credit facility of up to $50 million.

July 26, 2012

THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics receives approximately $4 million in proceeds from a private offering of convertible promissory notes and warrants.

July 26, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--RainDance Technologies Launches First Access Program for RainDrop Digital PCR System

July 26, 2012

SUMMIT, N.J.--(BUSINESS WIRE)--Protalex, Inc. (OTCBB: PRTX), a clinical stage biopharmaceutical company that is developing a class of drugs designed to treat a wide array of autoimmune and inflammatory diseases today announced preliminary...

July 26, 2012

WOBURN, Mass.--(BUSINESS WIRE)--ArQule announces date and time of Q2 2012 earnings release and call.

July 26, 2012

WATERTOWN, Mass.--(BUSINESS WIRE)--pSivida announces German Iluvien marketing Authorization for treatment of chronic DME - fifth European country to grant approval

July 26, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today that it has been issued a patent in Australia, patent number 2005325753, “Improved...

July 26, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Hyperion Therapeutics, Inc. (NASDAQ:HPTX) announced today the pricing of its initial public offering of 5,000,000 shares of its common stock at $10.00 per share, before underwriting discounts and...

July 26, 2012

DUBLIN, Ohio--(BUSINESS WIRE)--Lymphoseek® Data Presented by Independent Investigators at 8th International Conference on Head and Neck Cancer in July 2012